Skip to main content
. 2013 Oct 9;163(4):1792–1803. doi: 10.1104/pp.113.222828

Table I. CYP71D351 and CYP71D12 substrate specificities.

+ and – denote capacity and incapacity of hydroxylation. The conversion of substrates (%) is given in parentheses.

Substrate CYP71D351 CYP71D12
Naringenin
Tryptamine
Secologanin
Strictosidine
Ajmalicine
Tabersonine +++ (96.3 ± 0.6) +++ (93.6 ± 0.3)
2.3-Dihydrotabersonine + (31.3 ± 1.7) +/− (2.1 ± 0.2)
2.3-Dihydro-3-hydroxytabersonine + (18.2 ± 0.9) +/− (2.6 ± 0.2)
Vindoline
Catharanthine